Financials aap Implantate AG Xetra
Equities
AAQ
DE0005066609
Medical Equipment, Supplies & Distribution
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
0.73 EUR | -2.67% | -9.32% | -12.05% |
2021 | Aap Implantate AG Announces Sales Results for the Second Quarter and Half Year Ended 30 June 2021 | CI |
2021 | Aap Implantate Ag Reports Earnings Results for the Full Year Ended December 31, 2020 | CI |
Valuation
Fiscal Period: December | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|---|
Capitalization 1 | 51.52 | 32.4 | 11.93 | 10.1 | 14.93 | 8.047 |
Enterprise Value (EV) 1 | 36.68 | 25.93 | 10.27 | 13.07 | 17.91 | 10.98 |
P/E ratio | -5.56 x | -4.19 x | -0.61 x | -1.13 x | -5.85 x | -3.14 x |
Yield | - | - | - | - | - | - |
Capitalization / Revenue | 4.15 x | 2.56 x | 0.92 x | 1.07 x | 1.21 x | 0.69 x |
EV / Revenue | 2.95 x | 2.05 x | 0.79 x | 1.39 x | 1.46 x | 0.94 x |
EV / EBITDA | -6.37 x | -4.57 x | -0.57 x | -2.22 x | -7.3 x | -3.43 x |
EV / FCF | -20.3 x | -5.51 x | -1.1 x | -8.07 x | -7.2 x | -5.8 x |
FCF Yield | -4.92% | -18.2% | -90.5% | -12.4% | -13.9% | -17.2% |
Price to Book | 1.21 x | 0.93 x | 0.63 x | 0.98 x | 1.17 x | 0.69 x |
Nbr of stocks (in thousands) | 2,864 | 2,867 | 3,207 | 3,207 | 4,978 | 5,961 |
Reference price 2 | 17.99 | 11.30 | 3.720 | 3.150 | 3.000 | 1.350 |
Announcement Date | 30/03/18 | 30/04/19 | 30/06/20 | 30/04/21 | 31/03/22 | 29/04/23 |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|---|
Net sales 1 | 12.42 | 12.68 | 12.98 | 9.405 | 12.3 | 11.66 |
EBITDA 1 | -5.757 | -5.669 | -18.01 | -5.887 | -2.453 | -3.201 |
EBIT 1 | -6.96 | -6.832 | -19.28 | -7.441 | -3.353 | -4.042 |
Operating Margin | -56.04% | -53.89% | -148.49% | -79.12% | -27.26% | -34.67% |
Earnings before Tax (EBT) 1 | -9.3 | -7.648 | -20.04 | -8.816 | -2.864 | -3.613 |
Net income 1 | -9.271 | -7.666 | -19.44 | -8.937 | -2.522 | -2.564 |
Net margin | -74.65% | -60.47% | -149.73% | -95.02% | -20.5% | -22% |
EPS 2 | -3.237 | -2.700 | -6.100 | -2.787 | -0.5131 | -0.4305 |
Free Cash Flow 1 | -1.803 | -4.706 | -9.3 | -1.62 | -2.487 | -1.894 |
FCF margin | -14.52% | -37.12% | -71.63% | -17.23% | -20.22% | -16.25% |
FCF Conversion (EBITDA) | - | - | - | - | - | - |
FCF Conversion (Net income) | - | - | - | - | - | - |
Dividend per Share | - | - | - | - | - | - |
Announcement Date | 30/03/18 | 30/04/19 | 30/06/20 | 30/04/21 | 31/03/22 | 29/04/23 |
Balance Sheet Analysis
Fiscal Period: December | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|---|
Net Debt 1 | - | - | - | 2.97 | 2.97 | 2.94 |
Net Cash position 1 | 14.8 | 6.48 | 1.66 | - | - | - |
Leverage (Debt/EBITDA) | - | - | - | -0.5045 x | -1.212 x | -0.9172 x |
Free Cash Flow 1 | -1.8 | -4.71 | -9.3 | -1.62 | -2.49 | -1.89 |
ROE (net income / shareholders' equity) | -19% | -19.8% | -72.3% | -61.3% | -21.9% | -20% |
ROA (Net income/ Total Assets) | -7.61% | -9.21% | -35.2% | -20.2% | -9.82% | -11.7% |
Assets 1 | 121.8 | 83.2 | 55.26 | 44.19 | 25.67 | 21.91 |
Book Value Per Share 2 | 14.90 | 12.20 | 5.880 | 3.210 | 2.570 | 1.950 |
Cash Flow per Share 2 | 4.640 | 1.480 | 0.9100 | 0.2800 | 0.4200 | 0.0400 |
Capex | - | - | 0.41 | 0.33 | 0.33 | 0.34 |
Capex / Sales | - | - | 3.13% | 3.55% | 2.67% | 2.95% |
Announcement Date | 30/03/18 | 30/04/19 | 30/06/20 | 30/04/21 | 31/03/22 | 29/04/23 |
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-6.52% | 18TCr | |
-6.14% | 10TCr | |
-5.45% | 6.75TCr | |
-9.93% | 4.51TCr | |
+8.90% | 4.44TCr | |
+5.36% | 4.07TCr | |
+11.90% | 2.98TCr | |
+10.26% | 2.45TCr | |
-7.98% | 2.4TCr |
- Stock Market
- Equities
- AAQ1 Stock
- AAQ Stock
- Financials aap Implantate AG